Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 9350036Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2024
Linked Award Amount
$2.8M
Full award amounts, FY2024
Award Records
3
Records listing this PI
Award-Linked Rank
#2,916
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Prasad S. Adusumilli as a PI. Multi-PI records show the full award amount for context.
- 1UG3CA290241-01UG3CD28-KITv CAR T cells with PD-1 dominant negative receptor$1.5Maward amount
- 5R01CA235667-06R01A phase I/II combination immunotherapy clinical trial: mesothelin-targeted chimeric antigen receptor T cells and checkpoint blockade agent in pleural mesothelioma$691Kaward amount
- 1R01CA292664-01R01Tuning KITv CAR T cells for the solid tumor environment$655Kaward amount
Award organization
Organizations that administered FY2024 awards listing Prasad S. Adusumilli as a PI.
FY2024 award administered by Memorial Sloan Kettering Cancer Center (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardMemorial Sloan Kettering Cancer Center
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #2916
- 2024Entered Top 25% NationallyRanked #2916
- 2025$5M Cumulative Funding
- 2025R01 Grant Holder
- 2026Entered Top 10% NationallyRanked #1907